「pr」の検索結果
236件：161～165件目を表示
-
お知らせ | 千寿製薬株式会社
December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation chann...
https://www.senju.co.jp/english/news/ -
お知らせ | 千寿製薬株式会社
https://www.senju.co.jp/english/news/javascipt: void(0); -
Publications | Research & Development | SENJU Pharmaceutica
and Therapy. 2024 Oct;13(10):2629-2644. Identification of meibomian gland testosterone metabolites produced by tissue-intrinsic intracrine deactivation activity Khanh Tien Nguyen Pham 1, Takahito Miy...
http://www.senju.co.jp/english/rd/thesis/ -
Data And Statistics | About Senju | SENJU Pharmaceutical
les Revenue 2021.3 2022.3* 2023.3* 2024.3* 2025.3* Sales Revenue 40.7 40.8 46.4 48.9 48.9 Operating Profit 5.4 6.9 7.4 7.1 2.4 Ordinary Profit 8.0 9.1 8.7 9.1 2.9 Total Assets 75.8 83.9 88.2 98.4 100....
https://www.senju.co.jp/english/about/sales.html -
产品开发方针 | 研究与开发 | 千寿制药株式会社
。 #1: 井上 佐智子, 川岛 素子, 坪田 一男：什么是干眼症？从原因到最新的治疗，Farumashia，2014 50(3): 201-6 #2: Papas EB. The global prevalence of dry eye disease: A Bayesian view. Ophthalmic Physiol Opt. 2021;41(6):1254-66. #3: Uni...
http://www.senju.co.jp/chinese/rd/policy/